MHC-I genotype and tumor mutational burden predict response to immunotherapy.
Goodman AM, Castro A, Pyke RM, Okamura R, Kato S, Riviere P, Frampton G, Sokol E, Zhang X, Ball ED, Carter H, Kurzrock R.
Goodman AM, et al. Among authors: riviere p.
Genome Med. 2020 May 19;12(1):45. doi: 10.1186/s13073-020-00743-4.
Genome Med. 2020.
PMID: 32430031
Free PMC article.